Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsubishi UFJ Capital is one of Japan’s oldest and largest venture capital firms with a strong focus on life sciences. It manages several large funds dedicated to drug discovery startups and healthcare innovation. The firm invests in early to late-stage startups working on drug discovery, regenerative medicine, medical devices—including digital health—and supports commercialization from academia and corporate carveouts. It plays an active role in building Japan’s drug discovery ecosystem by facilitating partnerships between startups, academia, pharmaceutical companies, and contract manufacturers
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitsubishi UFJ Capital.